A New defense against the Superbugs?
It may be the most important breakthrough since the discovery of pennicilin. The October 13th issue on Nature reports the discovery of a new class of antibiotic that is proving to be highly effective against the bacteria Streptococcus Pneumoniae, and Streptococcus Pyogenes, including strains that are now resistant to antibiotics. These are the bacteria responsible for such diseases as meningitis, community-acquired pneumonia, strep throat, life-threatening sepsis, and flesh necrotic skin infections.
The team who made the discovery was a collaberation between researchers from Georgetown University Medical Center, David Geffen School of Medicine at UCLA, and Denmark-based biotech company Novozymes.
Please find the complete Science Daily article here: Article
It may be the most important breakthrough since the discovery of pennicilin. The October 13th issue on Nature reports the discovery of a new class of antibiotic that is proving to be highly effective against the bacteria Streptococcus Pneumoniae, and Streptococcus Pyogenes, including strains that are now resistant to antibiotics. These are the bacteria responsible for such diseases as meningitis, community-acquired pneumonia, strep throat, life-threatening sepsis, and flesh necrotic skin infections.
The team who made the discovery was a collaberation between researchers from Georgetown University Medical Center, David Geffen School of Medicine at UCLA, and Denmark-based biotech company Novozymes.
Please find the complete Science Daily article here: Article
posted by Ted Gavinski at 8:43 PM
0 Comments:
Post a Comment
<< Home